Bayer

Last updated January 31, 2026

432

Innovation Areas

13,147

Inventors

104

Collaborations

Mechanical occlusion fluid path cassette: BayerRecent Research Landscape

Contamination risks and setup delays in high-pressure angiography increase procedure costs and patient risk. These innovations utilize integrated retention cassettes and pressure release valves to ensure sterile integrity and rapid component replacement.

What technical problems is Bayer addressing in Mechanical occlusion fluid path cassette?

Inaccurate fluid delivery volume

(52)evidences

Inaccurate fluid delivery and undetected line contents pose immediate physiological threats. Eliminating these risks ensures patient safety during automated high-pressure injection protocols.

Accidental hazardous radiation exposure

(29)evidences

Unprotected connection points and interface surfaces are vulnerable to environmental pathogens and debris. Preventing ingress ensures patient safety and maintains sterile integrity during high-pressure injection procedures.